AstraZeneca, Isis Pharmaceuticals to Develop Antisense Drugs for ... - Drug Discovery Development PDF Print
Drug Discovery & Development
Isis Pharmaceuticals, Inc. and AstraZeneca today announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases. The new collaboration builds on a broad existing relationship between the ...
AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs ... PR Newswire (press release)
AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.